Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 88Leukemia, Myeloid, Acute 34Leukemia 32Myelodysplastic Syndromes 22Lymphoma, Follicular 18Lymphoma, Non-Hodgkin 16Lymphoma, B-Cell, Marginal Zone 16Lymphoma 16Lymphoma, Mantle-Cell 15Lymphoma, Large B-Cell, Diffuse 12Waldenstrom Macroglobulinemia 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Multiple Myeloma 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Leukemia, Myelomonocytic, Chronic 9Burkitt Lymphoma 9Hematologic Neoplasms 8Recurrence 7Lymphoma, T-Cell, Peripheral 7Lymphoma, Large-Cell, Immunoblastic 7Leukemia, Plasma Cell 7Lymphoma, Large-Cell, Anaplastic 6Leukemia, B-Cell 6Immunoblastic Lymphadenopathy 6Hodgkin Disease 6Sezary Syndrome 5Mycosis Fungoides 5Leukemia, Hairy Cell 5Intraocular Lymphoma 5Anemia 5

Interventions

ibrutinib 5ofatumumab 4Imatinib Mesylate 4Dasatinib 4nilotinib 3fludarabine 3bosutinib 3asciminib 3Rituximab 3Cyclophosphamide 3ruxolitinib 2obinutuzumab 2Sirolimus 2Mycophenolic Acid 2KW-2478 2Filgrastim 2Alemtuzumab 2posaconazole 1ponatinib 1pegfilgrastim 1oblimersen 1montelukast 1mocetinostat 1milatuzumab 1lonafarnib 1fenebrutinib 1abexinostat 1Whole-Body Irradiation 1Voriconazole 1Vision, Ocular 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bronchiolitis Obliterans Syndrome × Lenalidomide × Other hematologic neoplasm × Clear all
NCT01600053 2016-12-15

Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia

University of California, San Diego

Phase 2 Terminated
11 enrolled 4 charts
LymphoidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡